thank you

Recent Posts

• 1st Patient Enrolled in Phase 1 Trial of Antibody Therapy BHV-1100
• Optimal Dose of Tasquinimod Found in First Phase of RRMM Trial
• Blenrep-nirogacestat Combo Moves to Dose-testing Phase 2 of Trial
• FDA Expects Decision on Cilta-cel Approval by February 2022
• Xpovio Open to Advanced Myeloma Patients Outside US via Access Program